What's more, the dynamic change of PD-L1 expression on circulating tumor cells in advanced solid tumor patients undergoing PD-1 blockade therapy might serve as a predictor to indicate the therapeutic response at an early time (264). This evidence concerns the gene PDCD1 and neoplasm.